Lumida
/EWTX
⌘K
Edgewise Therapeutics Inc

Edgewise Therapeutics Inc

EWTX
$44.40USD+3.50%+1.50 today

MARKET CAP

4.8B

P/E (TTM)

FWD P/E

39.5x

DAY RANGE

$43 – $45

52W RANGE

$14
$48

AI Summary

Stalk
StalkMedium

While the medium-term structure remains bullish with a Stage 2 advance and a recent momentum breakout above consolidation, short-term exhaustion at the highs and extended price above EMAs suggest timing is poor. Execution is best deferred to a pullback into the rising EMAs and 50 SMA for an asymmetric entry.

  • Sale of muscular dystrophy unit raised $1.55B capital
  • Pro forma cash balance ~$2.01B bolsters R&D funding
  • Low profitability score highlights ongoing earnings struggles
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICTREND
Sales, Adj.
YoY %
P / Sales
EV / Sales
Gross Profit, Adj.
YoY %
Margin %
EV / Gross Profit
EBITDA, Adj.
YoY %
Margin %
EV / EBITDA
EBIT
YoY %
Margin %
EV / EBIT
Net Income
YoY %
Net Margin
EPS (GAAP)
YoY %